Kalaris Therapeutics KLRS
NASDAQ KLRS
$2.95 +0.05 (+1.72%)
As of: Sep 30, 2026 · 2:06 PM EDT

Kalaris Therapeutics (KLRS) Interest Coverage Ratio (2024 - 2025)

Updated

Kalaris Therapeutics' (KLRS) Interest Coverage Ratio was -31.98 for FY2025, compared with -19.15 in FY2024.

Analysis

Kalaris Therapeutics (KLRS) Interest Coverage Ratio (2024 - 2025) Analysis & Trends

  • According to Business Quant data, Interest Coverage Ratio came in at -19.15 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 25.41
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 10.28
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 7.27
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 5.22
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -42.08
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Kalaris Therapeutics 69.03 Mn 69.03 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -7.18
Dec 31, 2024 -5.45
Sep 30, 2024 -46.44
Jun 30, 2024 -8.39
Mar 31, 2024 -32.86
API Access

Kalaris Therapeutics Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=KLRS&period=max&api_key=YOUR_API_KEY